Thailand’s Joint Point Growery Sets Global Standard with EU-GACP Certification
Thai MJ Co. Ltd’s indoor facility gains international recognition for medical-grade cannabis cultivation, signaling a new era for Southeast Asia’s plant-based exports.
In a major advancement for Thailand’s medical cannabis sector, Thai MJ Co. Ltd — operating under the brand name Joint Point Growery — has officially earned EU Good Agricultural and Collection Practices (EU-GACP) certification from Control Union. This milestone places the company among a select few in the country to meet this globally recognized benchmark for quality, compliance, and pharmaceutical readiness in cannabis cultivation.
The EU-GACP certification, based on stringent standards from the World Health Organization (WHO) and the European Medicines Agency (EMEA), affirms that Joint Point Growery’s full production process — including cloning, drying, curing, packaging, and storage — aligns with best practices for the cultivation and post-harvest handling of Cannabis sativa for medicinal use.
Located just outside of Bangkok in Pathum Thani province, the company’s flagship facility spans 2,000 square meters of indoor grow space and is a model of technological precision. The infrastructure includes five 220-square-meter flowering rooms, each optimized for consistency, cleanliness, and efficiency. Purpose-built for sustainability, the facility features HEPA-filtered air systems, sandwich panel construction for insulation, epoxy-coated floors for sterility, precision irrigation, and full environmental automation. Together, these systems allow for tightly controlled growing conditions that meet European pharmaceutical standards — a rare feat in Asia’s emerging legal market.
The operation is led by a master grower with over 15 years of experience in California, bringing a Western pedigree to Joint Point’s cultivation strategy. The fusion of Thai innovation with international expertise has helped the company accelerate its readiness for export and pharmaceutical partnerships, making it a serious contender in the global supply chain.
“The GACP accreditation from EU Control Union is a significant technological benchmark for the industry,” says Ilya Bruman, CEO of Joint Point Growery. “It represents a major milestone not only for our company but for our entire group. Our next goals include achieving EU-GMP certification and expanding operations to include both indoor and greenhouse cultivation.”
That expansion is already underway. In addition to the indoor site, Thai MJ Co. Ltd has begun developing greenhouse facilities to scale production in response to increasing international demand. With full GACP compliance now secured, the company is uniquely positioned to supply pharmaceutical-grade products to both Thailand’s growing domestic market and to international buyers across Europe, where regulatory pathways for medical cannabis are rapidly maturing.
Thailand’s progressive stance on medical cannabis — the first Asian nation to legalize its use — has attracted global attention in recent years. Joint Point Growery’s success is a powerful example of how Thai producers can meet and exceed the compliance thresholds expected by international buyers, giving the country a competitive edge in a tightly regulated global industry.
As part of its mission to build visibility and foster global partnerships, the Joint Point team will be attending Mary Jane Berlin, Europe’s largest cannabis event, later this month. CEO Ilya Bruman and other company representatives will be on hand to meet with investors, distributors, and media as they continue expanding their European footprint.
For Thai MJ Co. Ltd, the GACP certification is more than a badge of honor — it’s a foundation for growth. With innovation-driven infrastructure, a commitment to international standards, and a strategic eye on global markets, Joint Point Growery is setting a new bar for what Southeast Asian cannabis can achieve.
